GenBioPro

GenBioPro
IndustryPharmaceutical
HeadquartersUnited States
Area served
United States
Productsmifepristone
Websitehttps://genbiopro.com/

GenBioPro is a United States pharmaceutical company which makes and distributes a generic version of the medication abortion drug mifepristone.

History

In 2019 GenBioPro obtained Food and Drug Administration (FDA) authorization to sell a generic version of mifepristone (before that, Danco Laboratories was the only company that distributed it in the United States).[1][2] Lauren Gardner, writing for Politico, reports that despite FDA's aim to approve generic drug applications in 10 months, the GenBioPro application (in 2009) was only approved after 10 years.[3]

In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.[4][5][needs update]

See also

References

  1. ^ North, Anna (20 August 2019). "The First Generic Abortion Pill Just Hit the US Market. Here's What That Means". Vox (Vox.com). Archived from the original on 13 July 2020. Retrieved 14 July 2020.
  2. ^ Perrone, Matthew (2025-10-02). "FDA Approves Another Generic Abortion Pill, Prompting Conservative Backlash". PBS. Associated Press. Retrieved 2026-05-04. The FDA approved the original version of mifepristone in 2000 and gradually eased access over time. That included approving the first generic pill, from drugmaker GenBioPro, in 2019.
  3. ^ Gardner, Lauren (2025-10-02). "FDA Approved New Generic Abortion Pill Before Shutdown". Politico. The agency typically aims to approve abbreviated new drug applications—those submitted for generics—within 10 months, but the process can take longer depending on how many questions or concerns reviewers have. There's also precedent for the FDA to take time on mifepristone decisions—GenBioPro, the first generic maker for the drug... applied for approval in 2009 and fielded a rejection in 2018 before getting approval the following year during the first Trump administration.
  4. ^ McCammon, Sarah (April 19, 2023). "Generic Abortion Pill Manufacturer Sues FDA in Effort to Preserve Access". NPR. Retrieved 2026-05-04.
  5. ^ Belluck, Pam (2023-04-19). "Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market". The New York Times. ISSN 0362-4331. Retrieved 2025-03-06.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.